Precision Medicine - LBS Healthcare Conference 21 November
London Business School’s Healthcare Conference takes place on 21 November at the Royal College of Physicians.
What if you could have medical treatment which takes into account your individual variability in genes, environment and lifestyle? It’s well-known that Steve Jobs spent over $100,000 to learn his cancer’s genetic information hoping to find the most suitable medical treatments. These tests were conducted by scientists from Foundation Medicine – a Boston-based diagnostics company counting Google and Bill Gates as investors. Genetic testing has also been in the news more recently, with companies like 23andMe, a California-based personal genomics and biotechnology company that offer affordable Personal Genome Services, giving customers the option to order a DNA collection kit online. When the kit is returned, customers receive personal reports as well as information on inherited conditions and genetic risk factors.
These are the examples of “Precision Medicine” - a concept to segregate patients into subgroups based on genetic information, environment and lifestyles and to design treatments based on these subgroups. This is a new technology that has become possible with recent technological developments and the benefits include improved treatment outcomes, reduced side-effects and better disease prevention. Accelerating the trend, Barack Obama announced a plan to invest $215m in “Precision Medicine Initiative” in January 2015. Precision Medicine has a possibility to change the landscape of healthcare for us not only in business, but as potential patients.
There is a diverse line-up of speakers from pharmaceutical companies, government, bio-pharma/tech start-ups and consultants in the field who will be discussing the progress of Precision Medicine and its situation in the UK.
Find out more and book tickets here.
If you have any questions about this conference, please contact Taku Edatsune.